Andreas Hochhaus

机构：Klinikum Magdeburg, Ernst Abbe University of Applied Sciences Jena, Jena University Hospital, Centrum für Integrierte Onkologie, DKFZ-ZMBH Alliance · ORCID：0000-0003-0626-0834

发表论文 1648 篇 · 总被引 92201 次 · h-index 129

代表论文

• Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial (2025 · Blood · 被引 12)
• Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective (2025 · Leukemia · 被引 4)
• Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes (2025 · Leukemia · 被引 2)
• Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial (2026 · Leukemia · 被引 1)
• Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression (2026 · BMC Cancer · 被引 1)
• ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors (2026 · Leukemia · 被引 1)